The global light therapy market size is expected to reach USD 1.44 billion by 2030, expanding at a CAGR of 4.6% during the forecast period, based on a new report by Grand View Research, Inc. The primary factor driving the growth is the expansion of the home healthcare industry and the preference for home light therapy devices. Additionally, advantages associated with the treatment such as fewer side effects, as well as improved focus, and reduced anxiety are fueling the demand.
Factors such as an increase in awareness about the benefits of light therapy, and an increase in health expenditure are driving the growth of the market. In addition, the presence of major players such as BioPhotas, Northern Light Technologies, Verilux, and others is influencing the market growth positively.
The COVID-19 pandemic negatively impacted the light therapy industry. Working from home led to higher adoption of light therapy devices. Increasing awareness about self-care and personal wellness has also driven the demand for light therapy. Moreover, increased investments in telemedicine and remote patient monitoring have fueled the demand in the market.
Some of the key players such as Koninklijke Philips N.V. and Beurer GmbH BioPhotasare are introducing innovative products, influencing the market growth positively. In April 2019, Philips introduced a multi-part program called VitalMinds as a non-pharmacological way to treat delirium in critical care unit (CCU) patients. The remedy entails the use of the CE-certified VitalSky individualized light treatment system, which provides a circadian-effective program to assist the patients' sleep-wake routine.
Request a free sample copy or view report summary: Light Therapy Market Report
Based on product, the handheld skin treatment devices segment accounted for the largest market share of 26.7% in 2022. The segment is also expected to witness the highest CAGR over the forecast period, which can be attributed to various skin conditions such as eczema, vitiligo, and psoriasis
Based on application, sleeping disorder accounted for the largest market share of over 23% in 2022 and is also expected to witness significant growth over the forecast period. This is attributed to the increasing screen time and work-stress
By light type, the blue light segment dominated the market with a revenue share of 42.8% in 2022. The use of blue light aids in faster and better treatment of psoriasis and is expected to fuel segment growth over the projected period
North America dominated the global light therapy industry with a revenue share of 36.3% in 2022. The market's growth in Canada is boosted by rising R&D spending and rising demand for precision medications. Collaborations between important businesses are further fostering the expansion
Grand View Research has segmented the global light therapy market based on product, application, light type, end-use, and region:
Light Therapy Product Outlook (Revenue, USD Million, 2017 - 2030)
Light Box
Floor and Desk Lamps
Handheld Devices for Skin Treatment
Light Visor
Dawn Simulator
Light Therapy Lamps
Light Therapy Application Outlook (Revenue, USD Million, 2017 - 2030)
Psoriasis
Vitiligo
Eczema
Acne Vulgaris
SAD/Winter Blues
Sleeping Disorders
Light Therapy Light Type Outlook (Revenue, USD Million, 2017 - 2030)
Blue Light
Red Light
White Light
Light Therapy End-use Outlook (Revenue, USD Million, 2017 - 2030)
Dermatology Clinics
Home Healthcare
Light Therapy Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Light Therapy Market
Koninklijke Philips N.V.
Beurer GmbH
BioPhotas
Northern Light Technologies
Lumie
Verilux, Inc.
Zepter International
The Daylight Company
Zerigo Health
Naturebright
"The quality of research they have done for us has been excellent..."